An Observational 1-Month Trial on the Efficacy and Safety of Promerim for Improving Knee Joint

Overview

Journal Clin Med Insights Arthritis Musculoskelet Disord

Publisher Sage Publications

Specialty Rheumatology

Date 2018 Feb 23

PMID 29467586

Citations 3

Authors

Bekir Eray Kilinc

Yunus Oc

Gungor Alibakan

Emre Bilgin

Muharrem Kanar

Osman Tugrul Eren

Affiliations

Soon will be listed here.

Abstract

Objective: This study was conducted to evaluate the efficacy and tolerability of the oral intake of promerim in the elimination of acute pain and discomfort associated with knee osteoarthritis (OA).

Methods: Single-center, 1-month, prospective, observational clinical trial. A total of 92 patients not older than 70 years were included. Patients were offered to use 720-mg promerim for the first 15 days after admission after breakfast and then 360 mg for the second 15 days. All patients were analyzed with the visual analog scale (VAS) for pain, which ranges from 0 to 10, and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score before the start of treatment and 1 month after the start. Statistical analysis was performed by SPSS 15.0 software. An α level of < .05 was assumed to be statistically significant.

Results: This study comprised 92 patients (69 women and 23 men) with a mean age of 51.5 (range: 40-69) years. Before treatment, the mean VAS score was 5.6 ± 1.1, and after treatment, the mean VAS score was 2.6 ± 1.7. Treatment with promerim consistently showed a significant decrease in the VAS score ( < .001). The mean WOMAC score of the patients was 46.4 ± 8.2 before treatment. After treatment, the mean WOMAC score was 72.1 ± 14.4. Treatment with promerim consistently showed a significant increase in the WOMAC score ( < .001).

Conclusions: The results of this single-center, open-label clinical study demonstrate that promerim is a viable natural treatment option for treating knee OA. We recommend that 720-mg promerim taken once daily for the first 15 days after admission and 360 mg taken once daily for the next 15 days significantly and rapidly reduced composite pain and stiffness in the knee OA within 1 month.

Citing Articles

Collagen Supplementation for Joint Health: The Link between Composition and Scientific Knowledge.

Martinez-Puig D, Costa-Larrion E, Rubio-Rodriguez N, Galvez-Martin P Nutrients. 2023; 15(6).

PMID: 36986062 PMC: 10058045. DOI: 10.3390/nu15061332.

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Gwinnutt J, Wieczorek M, Rodriguez-Carrio J, Balanescu A, Bischoff-Ferrari H, Boonen A RMD Open. 2022; 8(2).

PMID: 35654458 PMC: 9096533. DOI: 10.1136/rmdopen-2021-002167.

Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids.

Bourdon B, Contentin R, Casse F, Maspimby C, Oddoux S, Noel A Int J Mol Sci. 2021; 22(2).

PMID: 33430111 PMC: 7826754. DOI: 10.3390/ijms22020580.

References

Deeks J, Smith L, Bradley M . Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ. 2002; 325(7365):619. PMC: 126301. DOI: 10.1136/bmj.325.7365.619. View

Kellgren J, Lawrence J . Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16(4):494-502. PMC: 1006995. DOI: 10.1136/ard.16.4.494. View

Bresalier R, Sandler R, Quan H, Bolognese J, Oxenius B, Horgan K . Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005; 352(11):1092-102. DOI: 10.1056/NEJMoa050493. View

Gupta S, Hawker G, Laporte A, Croxford R, Coyte P . The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford). 2005; 44(12):1531-7. DOI: 10.1093/rheumatology/kei049. View

Clegg D, Reda D, Harris C, Klein M, ODell J, Hooper M . Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006; 354(8):795-808. DOI: 10.1056/NEJMoa052771. View

Nussmeier N, Whelton A, Brown M, Langford R, Hoeft A, Parlow J . Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005; 352(11):1081-91. DOI: 10.1056/NEJMoa050330. View

Shakibaei M, Kociok K, Forster C, Vormann J, Gunther T, Stahlmann R . Comparative evaluation of ultrastructural changes in articular cartilage of ofloxacin-treated and magnesium-deficient immature rats. Toxicol Pathol. 1996; 24(5):580-7. DOI: 10.1177/019262339602400507. View

Laine L . Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am. 1996; 6(3):489-504. View

Peat G, McCarney R, Croft P . Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001; 60(2):91-7. PMC: 1753462. DOI: 10.1136/ard.60.2.91. View

10.

Lawrence R, Felson D, Helmick C, Arnold L, Choi H, Deyo R . Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008; 58(1):26-35. PMC: 3266664. DOI: 10.1002/art.23176. View

11.

Hadler N . Osteoarthritis as a public health problem. Clin Rheum Dis. 1985; 11(2):175-85. View

12.

Gaby A . Natural treatments for osteoarthritis. Altern Med Rev. 1999; 4(5):330-41. View

13.

Case J, Baliunas A, Block J . Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med. 2003; 163(2):169-78. DOI: 10.1001/archinte.163.2.169. View

14.

Geba G, Weaver A, Polis A, Dixon M, Schnitzer T . Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA. 2002; 287(1):64-71. DOI: 10.1001/jama.287.1.64. View

15.

Liu X, Machado G, Eyles J, Ravi V, Hunter D . Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2017; 52(3):167-175. DOI: 10.1136/bjsports-2016-097333. View

16.

Singh G, Wu O, Langhorne P, Madhok R . Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther. 2006; 8(5):R153. PMC: 1779447. DOI: 10.1186/ar2047. View

17.

Towheed T, Maxwell L, Judd M, Catton M, Hochberg M, Wells G . Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006; (1):CD004257. PMC: 8275921. DOI: 10.1002/14651858.CD004257.pub2. View

18.

Boonmaleerat K, Wanachewin O, Phitak T, Pothacharoen P, Kongtawelert P . Fish Collagen Hydrolysates Modulate Cartilage Metabolism. Cell Biochem Biophys. 2017; 76(1-2):279-292. DOI: 10.1007/s12013-017-0817-2. View

19.

Raynauld J, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J . Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003; 48(2):370-7. DOI: 10.1002/art.10777. View

20.

Schadow S, Simons V, Lochnit G, Kordelle J, Gazova Z, Siebert H . Metabolic Response of Human Osteoarthritic Cartilage to Biochemically Characterized Collagen Hydrolysates. Int J Mol Sci. 2017; 18(1). PMC: 5297837. DOI: 10.3390/ijms18010207. View